UroGen Pharma Ltd. Weighted Average Number of Shares Outstanding, Basic and Diluted
UroGen Pharma Ltd. (URGN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 22.35 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-21.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-21
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 22.43M shares, a 1.28% increase year-over-year.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 22.38M shares, a 1.46% increase year-over-year.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 22.33M shares, a 2.66% increase year-over-year.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 22.24M shares, a 5.12% increase year-over-year.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 22.35M shares, a 2.60% increase from fiscal 2020.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 21.78M shares, a 6.10% increase from fiscal 2019.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 20.53M shares, a 30.31% increase from fiscal 2018.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 15.75M shares, a 62.13% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 22.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | 22.41M shares derived: average of 2 quarters · filed 2022-03-21 | 22.38M shares derived: average of 3 quarters · filed 2022-03-21 | 22.35M shares 10-K · filed 2022-03-21 |
| 2021-09-30 | 22.38M shares 10-Q · filed 2021-11-15 | 22.36M shares derived: average of 2 quarters · filed 2021-11-15 | 22.32M shares 10-Q · filed 2021-11-15 | 22.28M shares derived: average of 4 quarters · filed 2022-03-21 |
| 2021-06-30 | 22.33M shares 10-Q · filed 2021-08-04 | 22.29M shares 10-Q · filed 2021-08-04 | 22.24M shares derived: average of 3 quarters · filed 2022-03-21 | 22.20M shares derived: average of 4 quarters · filed 2022-03-21 |
| 2021-03-31 | 22.24M shares 10-Q · filed 2021-05-13 | 22.20M shares derived: average of 2 quarters · filed 2022-03-21 | 22.15M shares derived: average of 3 quarters · filed 2022-03-21 | 22.05M shares derived: average of 4 quarters · filed 2022-03-21 |
| 2020-12-31 | 22.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | 22.10M shares derived: average of 2 quarters · filed 2022-03-21 | 21.99M shares derived: average of 3 quarters · filed 2022-03-21 | 21.78M shares 10-K · filed 2022-03-21 |
| 2020-09-30 | 22.06M shares 10-Q · filed 2021-11-15 | 21.91M shares derived: average of 2 quarters · filed 2021-11-15 | 21.66M shares 10-Q · filed 2021-11-15 | 21.49M shares derived: average of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | 21.75M shares 10-Q · filed 2021-08-04 | 21.45M shares 10-Q · filed 2021-08-04 | 21.30M shares derived: average of 3 quarters · filed 2021-08-04 | 21.21M shares derived: average of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | 21.16M shares 10-Q · filed 2021-05-13 | 21.08M shares derived: average of 2 quarters · filed 2021-05-13 | 21.02M shares derived: average of 3 quarters · filed 2021-05-13 | 20.98M shares derived: average of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | 21.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 20.96M shares derived: average of 2 quarters · filed 2021-03-18 | 20.92M shares derived: average of 3 quarters · filed 2021-03-18 | 20.53M shares 10-K · filed 2021-03-18 |
| 2019-09-30 | 20.92M shares 10-Q · filed 2020-11-09 | 20.88M shares derived: average of 2 quarters · filed 2020-11-09 | 20.37M shares 10-Q · filed 2020-11-09 | 19.24M shares derived: average of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | 20.83M shares 10-Q · filed 2020-08-10 | 20.10M shares 10-Q · filed 2020-08-10 | 18.68M shares derived: average of 3 quarters · filed 2020-08-10 | 18.03M shares derived: average of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | 19.34M shares 10-Q · filed 2020-05-07 | 17.60M shares derived: average of 2 quarters · filed 2020-05-07 | 17.10M shares derived: average of 3 quarters · filed 2020-05-07 | 16.77M shares derived: average of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | 15.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 15.97M shares derived: average of 2 quarters · filed 2020-03-02 | 15.91M shares derived: average of 3 quarters · filed 2020-03-02 | 15.75M shares 10-K · filed 2020-03-02 |
| 2018-09-30 | 16.09M shares 10-Q · filed 2019-11-12 | 15.94M shares derived: average of 2 quarters · filed 2019-11-12 | 15.72M shares 10-Q · filed 2019-11-12 | 15.34M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | 15.78M shares 10-Q · filed 2019-08-09 | 15.53M shares 10-Q · filed 2019-08-09 | 15.08M shares derived: average of 3 quarters · filed 2020-03-02 | 14.58M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | 15.27M shares 10-Q · filed 2019-05-09 | 14.73M shares derived: average of 2 quarters · filed 2020-03-02 | 14.17M shares derived: average of 3 quarters · filed 2020-03-02 | 12.93M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | 14.20M shares derived: 10-K 12 month − 6-K 9 month · filed 2020-03-02 | 13.62M shares derived: average of 2 quarters · filed 2020-03-02 | 12.15M shares derived: average of 3 quarters · filed 2020-03-02 | 9.72M shares 10-K · filed 2020-03-02 |
| 2017-09-30 | 13.05M shares 6-K · filed 2018-11-13 | 11.13M shares derived: average of 2 quarters · filed 2018-11-13 | 8.22M shares 6-K · filed 2018-11-13 | |
| 2017-06-30 | 9.20M shares 6-K · filed 2018-08-14 | 5.76M shares 6-K · filed 2018-08-14 | ||
| 2017-03-31 | 2.31M shares 6-K · filed 2018-05-15 | |||
| 2016-12-31 | 2.31M shares 10-K · filed 2019-02-28 | |||
| 2015-12-31 | 2.30M shares 20-F · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |